EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics
Haemonetics Corporation (HAE)
Last haemonetics corporation earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=72118&p=irol-irhome
Company Research
Source: PR Newswire
EQT Life Sciences to exit portfolio company Vivasure Medical in sale to HaemoneticsVivasure's PerQseal® Elite system uses a special bioabsorbable patch to seal large access sites in arteries or veins from the inside EQT supported Vivasure from its Series C investment in 2016 through clinical development and toward market approvalSTOCKHOLM, Jan. 12, 2026 /PRNewswire/ -- EQT Life Sciences is pleased to announce that the LSP Health Economics Fund has exited Vivasure Medical Limited ("Vivasure" or the "Company"), a Galway, Ireland-based company pioneering next-generation technology for percutaneous vessel closure, through a sale to Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes.Vivasure's PerQseal® Elite system uses a special bioabsorbable patch to seal large access sites in arteries or veins from the inside, offering a sutureless, fully absorbable solution for structural heart and en
Show less
Read more
Impact Snapshot
Event Time:
HAE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HAE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HAE alerts
High impacting Haemonetics Corporation news events
Weekly update
A roundup of the hottest topics
HAE
News
- Haemonetics (NYSE:HAE) had its price target raised by analysts at Barrington Research from $90.00 to $93.00. They now have an "outperform" rating on the stock.MarketBeat
- EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics [Yahoo! Finance]Yahoo! Finance
- Vivasure Medical Announces Acquisition by Haemonetics Corporation [Yahoo! Finance]Yahoo! Finance
- Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.MarketBeat
- Vivasure Medical Announces Acquisition by Haemonetics CorporationBusiness Wire
HAE
Earnings
- 11/7/25 - Beat
HAE
Sec Filings
- 1/9/26 - Form 8-K
- 11/12/25 - Form 4
- 11/6/25 - Form 10-Q
- HAE's page on the SEC website